SBI Securities Co., Ltd.
Broker-DealerPosition in BTAI — BioXcel Therapeutics, Inc.
CIK 1851815
TOKYO, M0
Position in BTAI
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$18
-$252 QoQ
Shares Held
14
-91.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 40 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SBI Securities Co., Ltd. holds $3,193,853 across 54 Drug Manufacturers - Specialty & Generic names. BTAI ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
41,929 | $870,446 | |
| 2 | CGC |
Canopy Growth Corp
|
616,868 | $585,407 | |
| 3 | ZTS |
Zoetis Inc.
|
3,493 | $412,907 | |
| 4 | HLN |
Haleon plc
|
36,478 | $365,144 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
409 | $242,528 | |
| 6 | VTRS |
Viatris Inc
|
17,404 | $235,128 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
25,785 | $166,828 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
17,805 | $73,890 |
All Filings in BTAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18 | 14 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $270 | 169 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $432 | 169 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,590 | 879 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,727 | 851 | Shares | Defined | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||